Literature DB >> 26199095

Hospitalist attitudes toward the assessment and management of dyspnea in patients with acute cardiopulmonary diseases.

Mihaela S Stefan1,2,3, David H Au4, Richard A Mularski5, Jerry A Krishnan6, Eduard T Naureckas7, Shannon S Carson8, Patrick Godwin6, Aruna Priya1, Penelope S Pekow1,9, Peter K Lindenauer1,2,3.   

Abstract

BACKGROUND: Dyspnea is a common symptom in patients hospitalized with acute cardiopulmonary diseases. Routine assessment of dyspnea severity is recommended by clinical guidelines based on the evidence that patients are not treated consistently for dyspnea relief.
OBJECTIVE: To evaluate attitudes and beliefs of hospitalists regarding the assessment and management of dyspnea.
DESIGN: Cross-sectional survey. SETTINGS: Nine hospitals in the United States. MEASUREMENTS: Survey questions assessed the following domains regarding dyspnea: importance in clinical care, potential benefits and challenges of implementing a standardized assessment, current approaches to assessment, and how awareness of severity affects management. A 5-point Likert scale was used to assess the respondent's level of agreement; strongly agree and agree were combined into a single category.
RESULTS: Of the 255 hospitalists invited to participate, 69.8% completed the survey; 77.0% agreed that dyspnea relief is an important goal when treating patients with cardiopulmonary conditions. Approximately 90% of respondents stated that awareness of dyspnea severity influences their decision to intensify treatment, to pursue additional diagnostic testing, and the timing of discharge. Of the respondents, 61.0% agreed that standardized assessment of dyspnea should be part of the vital signs, and 64.6% agreed that awareness of dyspnea severity influences their decision to prescribe opioids. Hospitalists who appreciated the importance of dyspnea in clinical practice were more likely to support the implementation of a standardized scale.
CONCLUSIONS: Most hospitalists believe that routine assessment of dyspnea severity would enhance their clinical decision making and patient care. Measurement and documentation of dyspnea severity may represent an opportunity to improve dyspnea management.
© 2015 Society of Hospital Medicine.

Entities:  

Mesh:

Year:  2015        PMID: 26199095      PMCID: PMC4624477          DOI: 10.1002/jhm.2422

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.960


  20 in total

1.  Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma.

Authors:  K R Kendrick; S C Baxi; R M Smith
Journal:  J Emerg Nurs       Date:  2000-06       Impact factor: 1.836

2.  Hospitalist programs in the age of healthcare reform.

Authors:  Martin Buser
Journal:  J Healthc Manag       Date:  2010 Nov-Dec

3.  Defining and measuring quality palliative and end-of-life care in the intensive care unit.

Authors:  Richard A Mularski
Journal:  Crit Care Med       Date:  2006-11       Impact factor: 7.598

Review 4.  Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline.

Authors:  Darcy D Marciniuk; Donna Goodridge; Paul Hernandez; Graeme Rocker; Meyer Balter; Pat Bailey; Gord Ford; Jean Bourbeau; Denis E O'Donnell; Francois Maltais; Richard A Mularski; Andrew J Cave; Irvin Mayers; Vicki Kennedy; Thomas K Oliver; Candice Brown
Journal:  Can Respir J       Date:  2011 Mar-Apr       Impact factor: 2.409

5.  The Use of Hospitalists by Small Rural Hospitals: Results of a National Survey.

Authors:  Michelle M Casey; Peiyin Hung; Ira Moscovice; Shailendra Prasad
Journal:  Med Care Res Rev       Date:  2014-05-14       Impact factor: 3.929

6.  Validity of the numeric rating scale as a measure of dyspnea.

Authors:  A G Gift; G Narsavage
Journal:  Am J Crit Care       Date:  1998-05       Impact factor: 2.228

7.  Lung cancer and dyspnea: the patient's perception.

Authors:  M L Brown; V Carrieri; M J Dodd
Journal:  Oncol Nurs Forum       Date:  1986 Sep-Oct       Impact factor: 2.172

8.  Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease.

Authors:  Graeme Rocker; Joanne Young; Margaret Donahue; Morag Farquhar; Catherine Simpson
Journal:  CMAJ       Date:  2012-04-23       Impact factor: 8.262

9.  Using laboratory models to test treatment: morphine reduces dyspnea and hypercapnic ventilatory response.

Authors:  Robert B Banzett; Lewis Adams; Carl R O'Donnell; Sean A Gilman; Robert W Lansing; Richard M Schwartzstein
Journal:  Am J Respir Crit Care Med       Date:  2011-07-21       Impact factor: 21.405

10.  Dyspnea in terminally ill cancer patients.

Authors:  D B Reuben; V Mor
Journal:  Chest       Date:  1986-02       Impact factor: 9.410

View more
  2 in total

1.  Routine dyspnea assessment and documentation: Nurses' experience yields wide acceptance.

Authors:  Kathy M Baker; Susan DeSanto-Madeya; Robert B Banzett
Journal:  BMC Nurs       Date:  2017-01-14

2.  Attitude change and increased confidence with management of chronic breathlessness following a health professional training workshop: a survey evaluation.

Authors:  Kylie N Johnston; Mary Young; Debra Kay; Sara Booth; Anna Spathis; Marie T Williams
Journal:  BMC Med Educ       Date:  2020-03-30       Impact factor: 2.463

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.